Navigation Links
Hyperparathyroidism in Medical News

Nephrologists Indicate High Interest in AMAG Pharmaceuticals' Newly Approved Feraheme According to Latest BioTrends Report

... results from over 200 US Nephrologists. The survey was fielded in late May and focuses on trends in treatment patterns for renal anemia, secondary hyperparathyroidism and hyperphosphatemia. Nephrologists are extremely interested in AMAG's new IV iron product, Feraheme, which was approved by the FDA on June ...

Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model

... D hormone replacement therapies, calcitriol and paricalcitol (Zemplar(R)), the latter currently being the most widely used therapy for secondary hyperparathyroidism (SHPT) in the United States (U.S.). These data were presented in a poster presentation entitled "The Metabolic Profile of CTA018 Confers Therapeutic ...
Hyperparathyroidism in Medical Technology

Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection

... CTA018 has potential as a treatment for secondary hyperparathyroidism in chronic kidney disease (CKD). Blood samples ... is expected to be effective in treating secondary hyperparathyroidism but safer than currently available therapies. ... analogues are currently used to treat secondary hyperparathyroidism in CKD and end-stage renal disease. According to ...
Hyperparathyroidism in Medical Products

Osteocalcin IRMA Test

Description:... the liver [5]. Serum osteocalcin is elevated in disease states characterized by increased bone turnover such as renal osteodystrophy, osteoporosis, hyperparathyroidism and Pagets disease, and low in conditions associated with low bone turnover such as hypoparathyroidism and growth hormone deficiency [1]. Serum ...
Company:Diagnostic Systems Laboratories, Inc.

Osteocalcin ELISA Test

Description:... the liver [5]. Serum osteocalcin is elevated in disease states characterized by increased bone turnover such as renal osteodystrophy, osteoporosis, hyperparathyroidism and Pagets disease, and low in conditions associated with low bone turnover such as hypoparathyroidism and growth hormone deficiency [1]. Serum ...
Company:Diagnostic Systems Laboratories, Inc.
Hyperparathyroidism in Medical Definition

Pathology

... ) - Hypoglycemia - Hyperinsulinism - Zollinger-Ellison syndrome Parathyroid Hypoparathyroidism ( Pseudohypoparathyroidism ) - hyperparathyroidism ( Primary , Secondary , Tertiary ) Pituitary hyperfunction ( Acromegaly , Hyperprolactinaemia , Syndrome of inappropriate antidiuretic ...
Hyperparathyroidism in Medical Dictionary

Hyperparathyroidism

... hyperparathyroidism is caused by overactive parathyroid glands . ... levels of calcium in the blood stream. hyperparathyroidism - The over production of parat hormone by the ... hormone in an increased quantity). Primary hyperparathyroidism involves excessive production of parathyroid ...

Hypoparathyroidism

... thyroid gland . hypopituitarism ... Cure of hyperparathyroidism was achieved surgically in 89% of 1 large series ... . Five patients (9%) had recurrent hyperparathyroidism . Low levels of calcium in the blood can ... problem, namely hypoparathyroidism ... hyperparathyroidism , metastatic bone tumor , milk-alkali syndrome ...

Parathyroid glands

... hyperplasia causes about 15% of cases of hyperparathyroidism , which leads to elevated levels of calcium in ... thyroid gland ; parathyroid glands ; ... hyperparathyroidism is caused by overactive parathyroid glands . ... diagnosis of overactive parathyroid glands ( hyperparathyroidism ). Primary ...

PTH

... levels of PTH , the hallmark of secondary hyperparathyroidism , are associated with altered metabolism of ... and make too much PTH , a condition called hyperparathyroidism . This causes too much calcium to be found in ... hormone ) levels in the management of secondary hyperparathyroidism in patients undergoing chronic renal ... ...

Chronic renal failure

... D analog indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal failure . Dosage/administration: Recommended initial dose is 0.04 mcg/kg to 0. Secondary hyperparathyroidism is often seen in patients with chronic renal failure (CRF). Chronic ...

Hypercalcemia

... Names : Parathyroid-Related Hypercalcemia Definition Primary hyperparathyroidism involves excessive production of parathyroid hormone caused by ... levels. Hypercalcemia Abnormally high levels of blood calcium . hyperparathyroidism Overactivity of the parathyroid glands . Symptoms include generalized ...

Osteomalacia

... , rickets , bone tumors , or by overactive parathyroid glands ( hyperparathyroidism ). Normal healing of a bone fracture can also raise ALP levels. The ... and osteomalacia (both bone-weakening disease s). Another result of hyperparathyroidism is kidney stones , because of high levels of calcium excreted into the ...

Acromegaly

... , diabetes mellitus , acromegaly and some ... Endocrine problems most often include premature puberty , but can also include acromegaly , hyperparathyroidism , Vitamin D -resistant rickets , hyperthyroidism , and Cushing Syndrome . ...

Aplastic anemia

... . Secondary Aplastic Anemia secondary Cardiac Amyloidosis - AA Type ( Cardiac Amyloidosis ) Secondary Glaucoma ( Glaucoma ) Secondary hyperparathyroidism Secondary Hypogonadism (Hypogonadotropic Hypogonadism ) ... Conditions that can decrease WBC values include chemotherapy , aplastic anemia ...

Bone Diseases

... levels can be caused by bone diseases , such as Paget's disease , osteomalacia , rickets , bone tumors , or by overactive parathyroid glands ( hyperparathyroidism ). Normal healing of a bone fracture can also raise ALP levels. In fact, in one 2000 study, susceptibility to muscle and bone diseases was ...

More>>

Hyperparathyroidism in Biological Technology

Cytochroma and Mitsubishi Tanabe form partnership for chronic kidney disease therapies in U.S. and Asia

... an important validation of our novel approach to treating secondary hyperparathyroidism in CKD patients." MTPC's President and Representative Director, Natsuki ... in countries worldwide. About Secondary Hyperparathyroidism Secondary hyperparathyroidism ("SHPT") is a condition commonly associated with chronic kidney disease ...

Cytochroma initiates Phase I/II clinical trial of CTAP101 Capsules for vitamin D insufficiency in chronic kidney disease

... these patients have vitamin D insufficiency, which can lead to secondary hyperparathyroidism and resultant debilitating bone diseases. There is growing evidence that ... portfolio of new therapies for Vitamin D insufficiency and secondary hyperparathyroidism associated with CKD. In addition, the Company is developing novel ...

Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients

... require dialysis. Phosphate retention and the resulting hyperphosphatemia in patients with ESRD on dialysis are usually associated with secondary hyperparathyroidism (and its related cardiovascular complications), renal osteodystrophy and soft tissue mineralization. ESRD patients usually require treatment with ...

Cytochroma Closes $45 Million Series C Financing

... related to altered vitamin D metabolism in chronic kidney disease ("CKD") patients, and include CTA018 and CTAP201 for the treatment of secondary hyperparathyroidism ("SHPT"), and CTAP101 for the treatment of vitamin D insufficiency. These three lead products address significant markets that are expected to grow ...

Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc.

... has acquired ROCALTROL(R) (calcitriol) from Roche Laboratories Inc. ROCALTROL is a vitamin D analog prescribed by nephrologists for the management of hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (CRF) and by endocrinologists for the management of ...

Cytochroma Appoints R. Richard Wieland II As CFO

... has three lead product candidates in development for CKD patients: CTA018 and CTAP201 are being developed for the treatment of secondary hyperparathyroidism (SHPT), while CTAP101 is being developed for the treatment of Vitamin D insufficiency. About Chronic Kidney Disease According to the National ...

Cytochroma opens U.S. headquarters in Illinois

... has three lead product candidates in development for CKD patients: CTA018 and CTAP201 are being developed for the treatment of secondary hyperparathyroidism (SHPT), while CTAP101 is being developed for the treatment of Vitamin D insufficiency. About Chronic Kidney Disease According to the National ...

Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO

... for vitamin D deficiency and secondary hyperparathyroidism in patients with moderate-to-severe CKD. ... hyperparathyroidism. If untreated, secondary hyperparathyroidism can cause debilitating bone diseases and ... and preventing vitamin D deficiency and secondary hyperparathyroidism in CKD patients, but Dr. Geoffrey A. Block, ...

Bone Care Names New Chairman

... commercializing improved vitamin D-hormone therapies to treat secondary hyperparathyroidism in patients with kidney (renal) disease, osteoporosis and psoriasis. The ... Injection and Hectorol(R) Capsules for the treatment of secondary hyperparathyroidism in patients with end-stage renal ....

Americas Third Coast nurtures biotechnology

... ) specializes in novel vitamin D therapies for people with chronic kidney disease (CKD). The companys main drug, Hectorol, treats secondary hyperparathyroidism (SHPT) in patients with CKD. Healthy kidneys produce D hormone, which regulates calcium balance. Left untreated, low D hormone levels often ...

More>>

Hyperparathyroidism in Biological Dictionary

Parathyroid glands

... producing an excess ... Parathyroid Glands • hyperparathyroidism Treatments • hyperparathyroidism Surgery • Contact Us ... Easy to understand ... Your Parathyroid Glands . Hypoparathyroidism. hyperparathyroidism ... Fortunately for most people, most of the ...
Other Contents
(Date:7/9/2014)... signals active in almost all types of cancer sends ... may help fuel a tumour,s uncontrolled growth, new research ... London, identified a molecular trigger responsible for ratcheting up ... factory that makes the building blocks cancer cells need ... signalling pathway, called SREBP, controls the flow of messages ...
(Date:7/9/2014)... PROVIDENCE, R.I. Researchers have found that fecal ... difficile in immunocompromised patients. This is the result ... gastroenterologist in the Center for Women,s Gastrointestinal Medicine at ... have been published online in advance of print in ... Clostridium difficile , or C. diff , has ...
(Date:7/9/2014)... There has been a sharp increase in the ... using MyChart, the online, interactive service that allows patients ... healthcare providers, schedule appointments, and renew prescriptions. , Over ... MyChart each year increased five-fold, while the ... 10-fold, according to a study by Dr. David ...
(Date:7/9/2014)... Institute of Allergy and Infectious Diseases (NIAID), part ... an early-stage clinical trial of CRS3123, an investigational ... ( C. difficile ) infection. CRS3123 (previously ... inhibits C. difficile growth while sparing normal intestinal ... up to 30 healthy men and women ages ...
(Date:7/9/2014)... , , , , , ... , , , , ... assault rifle and the microphone is 50m downrange from the firer and approximately 30cm from the bullet... , ... , , , , , ... , , , , , , ...
Breaking Medicine News(10 mins):Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 4Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 5Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 6Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 7
(Date:7/9/2014)... Emerging fungal pathogens pose a greater threat to ... declines of amphibians, bats, corals, bees and snakes. ... published in the prestigious journal Nature ... resistance to a deadly chytrid fungus implicated in ... is important because it is the basis of ...
(Date:7/9/2014)... 2014Biofuels derived from the oils produced by algae may ... achieve this goal, optimization of cost effective strategies for ... is needed. Sapphire Energy has developed an innovative solution ... cultivation systems, described in Industrial Biotechnology , a ... article is available on the Industrial Biotechnology ...
(Date:7/9/2014)... Genome Atlas (TCGA) Research Network have identified novel ... adenocarcinoma, the most common subtype of lung cancer. ... number of possible therapeutic targets for this disease ... with treatable mutations because many potent cancer drugs ... is jointly funded and managed by the National ...
Breaking Biology News(10 mins):USF study: Amphibians can acquire resistance to deadly fungus 2Controlling contamination in open algae ponds for biofuels 2Study identifies novel genomic changes in the most common type of lung cancer 2Study identifies novel genomic changes in the most common type of lung cancer 3
Other TagsOther Tags